HICC: Humoral Immune Correlates for COVID19: Defining protective responses and critical readouts for Clinical Trials of Vaccines and Therapeutics

Key facts

Disease
COVID-19
Start & end year
2020
2022
Known Financial Commitments (USD)
$1,921,735.46
Funder
Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)
Principal Investigator
N/A
Research Location
United Kingdom
Lead Research Institution
University of Cambridge
Research Priority Alignment
N/A

Not Available

Last Updated:41 minutes ago

Authors
Liew F, Talwar S, Cross A, Willett BJ, Scott S, Logan N, Siggins MK, Swieboda D, Sidhu JK, Efstathiou C, Moore SC, Davis C, Mohamed N, Nunag J, King C, Thompson AAR, Rowland-Jones SL, Docherty AB, Chalmers JD, Ho LP, Horsley A, Raman B, Poinasamy K, Marks M, Kon OM, Howard L, Wootton DG, Dunachie S, Quint JK, Evans RA, Wain LV, Fontanella S, de Silva TI, Ho A, Harrison E, Baillie JK, Semple MG, Brightling C, Thwaites RS, Turtle L, Openshaw PJM, ISARIC4C Investigators, PHOSP-COVID collaborative group.
Publish Year
2023
Journal
EBioMedicine
DOI
10.1016/j.ebiom.2022.104402

Authors
Castillo-Olivares J, Wells DA, Ferrari M, Chan ACY, Smith P, Nadesalingam A, Paloniemi M, Carnell GW, Ohlendorf L, Cantoni D, Mayora-Neto M, Palmer P, Tonks P, Temperton NJ, Peterhoff D, Neckermann P, Wagner R, Doffinger R, Kempster S, Otter AD, Semper A, Brooks T, Albecka A, James LC, Page M, Schwaeble W, Baxendale H, Heeney JL.
Publish Year
2021
Journal
Frontiers in immunology
DOI
10.3389/fimmu.2021.748291